91 related articles for article (PubMed ID: 35407632)
1. Vitamin D status and the immune assessment in 22q11.2 deletion syndrome.
Legitimo A; Bertini V; Costagliola G; Baroncelli GI; Morganti R; Valetto A; Consolini R
Clin Exp Immunol; 2020 Jun; 200(3):272-286. PubMed ID: 32149392
[TBL] [Abstract][Full Text] [Related]
2. Understanding the Variability of 22q11.2 Deletion Syndrome: The Role of Epigenetic Factors.
Cillo F; Coppola E; Habetswallner F; Cecere F; Pignata L; Toriello E; De Rosa A; Grilli L; Ammendola A; Salerno P; Romano R; Cirillo E; Merla G; Riccio A; Pignata C; Giardino G
Genes (Basel); 2024 Feb; 15(3):. PubMed ID: 38540380
[TBL] [Abstract][Full Text] [Related]
3. Congenital Heart Defects and Dysmorphic Facial Features in Patients Suspicious of 22q11.2 Deletion Syndrome in Southern Brazil.
Diniz BL; Santos AS; Glaeser AB; Guaraná BB; Lorea CF; Josahkian JA; Huber J; Rosa RFM; Zen PRG
J Pediatr Genet; 2020 Dec; 9(4):227-234. PubMed ID: 32733742
[TBL] [Abstract][Full Text] [Related]
4. 22q11.2 microdeletion and increased risk for type 2 diabetes.
Van L; Heung T; Malecki SL; Fenn C; Tyrer A; Sanches M; Chow EWC; Boot E; Corral M; Dash S; George SR; Bassett AS
EClinicalMedicine; 2020 Sep; 26():100528. PubMed ID: 33089125
[TBL] [Abstract][Full Text] [Related]
5. Distinct Immunophenotypic Features in Patients Affected by 22q11.2 Deletion Syndrome with Immune Dysregulation and Infectious Phenotype.
Costagliola G; Legitimo A; Bertini V; Alberio AMQ; Valetto A; Consolini R
J Clin Med; 2023 Dec; 12(24):. PubMed ID: 38137647
[TBL] [Abstract][Full Text] [Related]
6. The Genetics and Epigenetics of 22q11.2 Deletion Syndrome.
Du Q; de la Morena MT; van Oers NSC
Front Genet; 2019; 10():1365. PubMed ID: 32117416
[TBL] [Abstract][Full Text] [Related]
7. Co-existence of other copy number variations with 22q11.2 deletion or duplication: a modifier for variable phenotypes of the syndrome?
Li D; Tekin M; Buch M; Fan YS
Mol Cytogenet; 2012 Apr; 5(1):18. PubMed ID: 22487416
[TBL] [Abstract][Full Text] [Related]
8. Late-Onset 22q11.2 Deletion Syndrome With Mild Cardiac Phenotype: A Unique Adult Presentation Diagnosed at 45 Years of Age.
Elizondo-Plazas A; Lopez-Uriarte GA; Gonzalez-Gonzalez JG; Rodriguez-Gutierrez R; Martinez-Villarreal L; Trevino-Juarez AS; Gonzalez-Velazquez CD
Cureus; 2023 Dec; 15(12):e50367. PubMed ID: 38213379
[TBL] [Abstract][Full Text] [Related]
9. Two patients with small chromosome 22q11.21 alterations and central nervous system abnormalities.
Guy C; Wang X; Lu X; Lu J; Li S
Mol Cytogenet; 2015; 8():102. PubMed ID: 26719767
[TBL] [Abstract][Full Text] [Related]
10. Opinion paper: effectiveness of sirolimus in treating partial Di George syndrome with autoimmune lymphoproliferative syndrome-like features.
van der Werff Ten Bosch J
Front Pediatr; 2023; 11():1242652. PubMed ID: 38078335
[TBL] [Abstract][Full Text] [Related]
11. Correction to: Clinical Practice Guidelines for the Immunological Management of Chromosome 22q11.2 Deletion Syndrome and Other Defects in Thymic Development.
Mustillo PJ; Sullivan KE; Chinn IK; Notarangelo LD; Haddad E; Davies EG; de la Morena MT; Hartog N; Yu JE; Hernandez-Trujillo VP; Ip W; Franco J; Gambineri E; Hickey SE; Varga E; Markert ML
J Clin Immunol; 2024 Jan; 44(2):53. PubMed ID: 38252398
[No Abstract] [Full Text] [Related]
12. Corrigendum to "Plasma cells are essentially absent in the luminal gastrointestinal tract of patients with "complete" 22q11.2 Deletion Syndrome (DiGeorge Syndrome)." [Human Pathology (2021) 117, 1e8].
Pendse AA; Maule JG; Neff JL; McCall S
Hum Pathol; 2024 Mar; ():. PubMed ID: 38556400
[No Abstract] [Full Text] [Related]
13. Hormonal, Genetic, Immunological: An Array of Mechanisms but How Do They Interact, If at All?
Balthazart J; Roselli CE
Arch Sex Behav; 2023 Oct; 52(7):2963-2971. PubMed ID: 36376746
[No Abstract] [Full Text] [Related]
14. Characterization of Autoimmune Thyroid Disease in a Cohort of 73 Paediatric Patients Affected by 22q11.2 Deletion Syndrome: Longitudinal Single-Centre Study.
Ricci S; Sarli WM; Lodi L; Canessa C; Lippi F; Azzari C; Stagi S
Genes (Basel); 2022 Aug; 13(9):. PubMed ID: 36140720
[TBL] [Abstract][Full Text] [Related]
15. Risk of thyroid neoplasms in patients with 22q11.2 deletion and DiGeorge-like syndromes: an insight for follow-up.
Sarli WM; Ricci S; Lodi L; Cavone F; Pacillo L; Giancotta C; Ubertini G; Baroncelli G; Cancrini C; Azzari C; Stagi S
Front Endocrinol (Lausanne); 2023; 14():1209577. PubMed ID: 37635986
[TBL] [Abstract][Full Text] [Related]
16. Primary Immunodeficiencies: Pathogenetic Advances, Diagnostic and Management Challenges.
Costagliola G; Consolini R
J Clin Med; 2023 Jul; 12(14):. PubMed ID: 37510766
[TBL] [Abstract][Full Text] [Related]
17. Heart Disease Characterization and Myocardial Strain Analysis in Patients with
Latorre-Pellicer A; Trujillano L; Del Rincón J; Peña-Marco M; Gil-Salvador M; Lucia-Campos C; Arnedo M; Puisac B; Ramos FJ; Ayerza-Casas A; Pié J
J Clin Med; 2023 Jun; 12(12):. PubMed ID: 37373745
[TBL] [Abstract][Full Text] [Related]
18. Clinical, Immunological, and Genetic Findings in a Cohort of Patients with the DiGeorge Phenotype without 22q11.2 Deletion.
Alberio AMQ; Legitimo A; Bertini V; Baroncelli GI; Costagliola G; Valetto A; Consolini R
J Clin Med; 2022 Apr; 11(7):. PubMed ID: 35407632
[TBL] [Abstract][Full Text] [Related]
19. Clinical Phenotype, Immunological Abnormalities, and Genomic Findings in Patients with DiGeorge Spectrum Phenotype without 22q11.2 Deletion.
Cirillo E; Prencipe MR; Giardino G; Romano R; Scalia G; Genesio R; Nitsch L; Pignata C
J Allergy Clin Immunol Pract; 2020 Oct; 8(9):3112-3120. PubMed ID: 32668295
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
